650 related articles for article (PubMed ID: 26603174)
1. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW
Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
[TBL] [Abstract][Full Text] [Related]
2. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Grigg MJ; William T; Dhanaraj P; Menon J; Barber BE; von Seidlein L; Rajahram G; Price RN; Anstey NM; Yeo TW
BMJ Open; 2014 Aug; 4(8):e006005. PubMed ID: 25138814
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Grigg MJ; William T; Menon J; Barber BE; Wilkes CS; Rajahram GS; Edstein MD; Auburn S; Price RN; Yeo TW; Anstey NM
Clin Infect Dis; 2016 Jun; 62(11):1403-1411. PubMed ID: 27107287
[TBL] [Abstract][Full Text] [Related]
4. Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.
Grigg MJ; William T; Barber BE; Rajahram GS; Menon J; Schimann E; Wilkes CS; Patel K; Chandna A; Price RN; Yeo TW; Anstey NM
Clin Infect Dis; 2018 Jan; 66(2):229-236. PubMed ID: 29020373
[TBL] [Abstract][Full Text] [Related]
5. The Treatment of Plasmodium knowlesi Malaria.
Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM
Trends Parasitol; 2017 Mar; 33(3):242-253. PubMed ID: 27707609
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
7. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Rueangweerayut R; Phyo AP; Uthaisin C; Poravuth Y; Binh TQ; Tinto H; Pénali LK; Valecha N; Tien NT; Abdulla S; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
N Engl J Med; 2012 Apr; 366(14):1298-309. PubMed ID: 22475593
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
[TBL] [Abstract][Full Text] [Related]
9. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
[TBL] [Abstract][Full Text] [Related]
10. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S
PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583
[TBL] [Abstract][Full Text] [Related]
11. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
William T; Menon J; Rajahram G; Chan L; Ma G; Donaldson S; Khoo S; Frederick C; Jelip J; Anstey NM; Yeo TW
Emerg Infect Dis; 2011 Jul; 17(7):1248-55. PubMed ID: 21762579
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
13. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
14. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C
Malar J; 2009 Jan; 8():10. PubMed ID: 19138388
[TBL] [Abstract][Full Text] [Related]
15. Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections.
Daneshvar C; Davis TM; Cox-Singh J; Rafa'ee MZ; Zakaria SK; Divis PC; Singh B
Malar J; 2010 Aug; 9():238. PubMed ID: 20723228
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin-based combination therapy for knowlesi malaria.
Ramharter M
Lancet Infect Dis; 2016 Feb; 16(2):134-6. PubMed ID: 26603170
[No Abstract] [Full Text] [Related]
17. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand.
Looareesuwan S; Wilairatana P; Molunto W; Chalermrut K; Olliaro P; Andrial M
Am J Trop Med Hyg; 1997 Sep; 57(3):348-53. PubMed ID: 9311648
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Marquiño W; Huilca M; Calampa C; Falconí E; Cabezas C; Naupay R; Ruebush TK
Am J Trop Med Hyg; 2003 May; 68(5):608-12. PubMed ID: 12812355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
